ROCK-TRED II, LLC – Trademark Portfolio
Entity Type: 16
ROCK-TRED II, LLC owns a portfolio of 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as BAG-PAK, CHEM-ROCK, and ELASTI-POXI. Of these, 3 are registered. The portfolio spans 6 Nice Classification classes, led by Class 2 (Paints) and Class 19 (Building Materials). Headquartered in WAUKEGAN, IL.
405 OAKWOOD AVENUE
WAUKEGAN, IL 60085
Showing of trademarks Trademarks
Trademark Classifications
ROCK-TRED II, LLC's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Paints, varnishes, lacquers; preservatives against rust and against deterioration of wood
Building materials (non-metallic); non-metallic rigid pipes for building
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does ROCK-TRED II, LLC have?
ROCK-TRED II, LLC has 15 U.S. trademarks filed with the USPTO. Of these, 3 registered, 12 cancelled.
What trademark classes does ROCK-TRED II, LLC file in?
ROCK-TRED II, LLC files trademarks across 6 Nice Classification classes. The most active classes are Class 2 (Paints), Class 19 (Building Materials), Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 20 (Furniture). Class 2 covers paints, varnishes, lacquers; preservatives against rust and against deterioration of wood.
What are ROCK-TRED II, LLC's most well-known trademarks?
ROCK-TRED II, LLC's registered trademark portfolio includes well-known marks such as BAG-PAK, CHEM-ROCK, and ELASTI-POXI. These are among 3 currently registered trademarks in the portfolio.
What is ROCK-TRED II, LLC's trademark registration success rate?
ROCK-TRED II, LLC has a 20% trademark registration rate, with 3 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.